Provided by Tiger Fintech (Singapore) Pte. Ltd.

Foghorn Therapeutics Inc.

4.43
-0.0500-1.12%
Post-market: 4.430.00000.00%17:45 EDT
Volume:44.98K
Turnover:202.20K
Market Cap:246.28M
PE:-2.42
High:4.73
Open:4.57
Low:4.39
Close:4.48
Loading ...

After Plunging -30.17% in 4 Weeks, Here's Why the Trend Might Reverse for Foghorn Therapeutics (FHTX)

Zacks
·
12 Dec 2024

Analysts Conflicted on These Healthcare Names: Solid Biosciences (SLDB), Foghorn Therapeutics (FHTX) and KalVista Pharmaceuticals (KALV)

TIPRANKS
·
06 Dec 2024

Foghorn Therapeutics (FHTX) Upgraded to Buy: Here's Why

Zacks
·
30 Nov 2024

We Think Foghorn Therapeutics (NASDAQ:FHTX) Needs To Drive Business Growth Carefully

Simply Wall St.
·
06 Nov 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
05 Nov 2024

Foghorn Therapeutics Reports Third Quarter Highlights

TIPRANKS
·
05 Nov 2024

TD Cowen Keeps Their Buy Rating on Foghorn Therapeutics (FHTX)

TIPRANKS
·
05 Nov 2024

Foghorn Therapeutics Inc. (FHTX) Reports Q3 Loss, Misses Revenue Estimates

Zacks
·
05 Nov 2024

Foghorn Therapeutics Q3 2024 GAAP EPS $(0.31) Beats $(0.41) Estimate, Collaboration Revenue $7.8M

Benzinga
·
05 Nov 2024

BRIEF-Foghorn Therapeutics Q3 EPS USD -0.31

Reuters
·
05 Nov 2024

Foghorn Therapeutics Inc.: Cash, Cash Equivalents, and Marketable Securities of $267.4 Mln as of September 30, 2024, Provides Cash Runway Into 2027

THOMSON REUTERS
·
05 Nov 2024

Foghorn Therapeutics Inc. expected to post a loss of 44 cents a share - Earnings Preview

Reuters
·
29 Oct 2024

BRIEF-Flagship Pioneering Announces Appointment Of Junaid Bajwa As Senior Partner, Head Of United Kingdom, And Science Partner For Pioneering Intelligence

Reuters
·
23 Oct 2024

Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence

THOMSON REUTERS
·
23 Oct 2024

Press Release: Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence

Dow Jones
·
23 Oct 2024

Foghorn Therapeutics Unveils Clinical Pipeline Progress

TIPRANKS
·
10 Oct 2024